RADNOR, Penn. & GÖTEBORG, Sweden--(BUSINESS WIRE)--Cortendo AB [ticker: CORT on NOTC-A], a global biopharmaceutical company focused on orphan endocrine disorders, today held an Extraordinary General Meeting in Göteborg. Approximately 64% of the 87.4 million outstanding shares were represented at the Extraordinary General Meeting. The meeting unanimously approved all corporate proposals.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
